Phil Bendick received his BS and MS from MIT and his PhD from Stanford University. As an Assistant Professor of Electrical Engineering at Purdue University from 1973 to 1975 he helped establish the Medical Ultrasound Research Laboratory and worked on the development of random signal processing techniques for blood flow detection and measurement, precursors to today’s coded excitation and B-flow techniques.
Bendick became involved with the clinical application of ultrasound with his move in 1976 to the Indiana University Medical Center in Indianapolis, where he established the noninvasive Vascular Laboratories for the University Hospital, Wishard Memorial Hospital (county hospital) and the VA Hospital. In 1986 he moved to William Beaumont Hospital in Royal Oak, Michigan (a suburb of Detroit) as Director of Surgical Research and established the Vascular Laboratory there, where he remains technical director of a department performing over 25,000 non-invasive vascular studies per year.
Dr. Bendick has authored or co-authored over 130 papers in peer reviewed journals and 17 book chapters, and made over 200 presentations at regional, national and international meetings. He was a founding member of the Board of Directors of the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL) and has served on the Board of Governors of the American Institute of Ultrasound in Medicine (AIUM).
In addition to his ongoing clinical activities his research interests encompass a wide spectrum including the natural history and noninvasive evaluation of cardiovascular disease, peripheral vascular applications of ultrasound contrast agents, quantitative measurement of healthcare quality, and the impact of accreditation on healthcare quality.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM